Immuneering Corporation (IMRX) vs Lexeo Therapeutics, Inc. (LXEO)
Immuneering Corporation and Lexeo Therapeutics, Inc. are both Biotechnology companies. Immuneering Corporation and Lexeo Therapeutics, Inc. are of similar size ($280.8M and $278.3M). Across the 10 metrics below, Immuneering Corporation leads on 5 and Lexeo Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | IMRX | LXEO | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (52.15%) | (46.76%) | (57.72%) |
| Return on assets | (47.31%) | (40.50%) | (49.22%) |
| Return on invested capital | (97.14%) | (253.48%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack